Pricing Log in Create free account

MediWound Ltd. (MDWD) vs PepGen, Inc. (PEPG)

MediWound Ltd. and PepGen, Inc. are both Biotechnology companies. MediWound Ltd. and PepGen, Inc. are of similar size ($184.0M and $171.1M). PepGen, Inc. has the higher net margin (0.00% vs −170.1%) and the higher return on invested capital (−2,076.3% vs −6,551.8%). Across the 13 metrics below, PepGen, Inc. leads on 7 and MediWound Ltd. on 6.

Valuation

Metric MDWD PEPG Biotechnology median
P/E n/m n/m 10.60
P/S 15.48 n/m 9.40
P/B 5.15 1.43 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 12.58 n/m 9.02
Earnings yield (11.23%) (53.04%) (32.88%)
Free cash flow yield (15.56%) (40.66%) (23.13%)

Profitability

Metric MDWD PEPG Biotechnology median
Gross margin 15.46% 0.00% 68.51%
Operating margin (267.75%) 0.00% 0.00%
Net margin (170.10%) 0.00% 0.00%
Free cash flow margin (240.47%) 0.00% 0.00%
Return on equity (75.42%) (75.45%) (51.96%)
Return on assets (29.06%) (59.06%) (46.06%)
Return on invested capital (6,551.77%) (2,076.25%) 0.00%

Growth

Metric MDWD PEPG Biotechnology median
Revenue growth (TTM) (40.26%) — 6.76%
EPS growth (last fiscal year) 30.69% 25.61% 29.88%
Revenue growth, 5-year CAGR (4.87%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MDWD PEPG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.32 13.36 4.97
Net debt to EBITDA 2.27 1.64 1.01

Dividend

Metric MDWD PEPG Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MDWD PEPG Biotechnology median
Market cap 183.97m 171.07m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack